HOUDA BENRAHMA

Prof. Dr. HOUDA BENRAHMA

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
TATarek Alouane
Tarek Alouane
MLMeriem laamarti
Meriem laamarti
AEAbdelomunim Essabbar
Abdelomunim Essabbar
MHMohammed Hakmi
Mohammed Hakmi
EBEl mehdi Bouricha
El mehdi Bouricha
AIAzeddine IBRAHIMI
Azeddine IBRAHIMI
The COVID-19 pandemic has been ongoing since its onset in late November 2019 in Wuhan, China. Understanding and monitoring the genetic evolution of the virus, its geographical characteristics, and its stability are particularly important for controlling the spread of the disease and especially for the development of a universal vaccine covering all circulating strains. From this perspective, we analyzed 30,983 complete SARS-CoV-2 genomes from 79 countries located in the six continents and collected from 24 December 2019, to 13 May 2020, according to the GISAID database. Our analysis revealed the presence of 3206 variant sites, with a uniform distribution of mutation types in different geographic areas. Remarkably, a low frequency of recurrent mutations has been observed; only 169 mutations (5.27%) had a prevalence greater than 1% of genomes. Nevertheless, fourteen non-synonymous hotspot mutations (>10%) have been identified at different locations along the viral genome; eight in ORF1ab polyprotein (in nsp2, nsp3, transmembrane domain, RdRp, helicase, exonuclease, and endoribonuclease), three in nucleocapsid protein, and one in each of three proteins: Spike, ORF3a, and ORF8. Moreover, 36 non-synonymous mutations were identified in the receptor-binding domain (RBD) of the spike protein with a low prevalence (<1%) across all genomes, of which only four could potentially enhance the binding of the SARS-CoV-2 spike protein to the human ACE2 receptor. These results along with intra-genomic divergence of SARS-CoV-2 could indicate that unlike the influenza virus or HIV viruses, SARS-CoV-2 has a low mutation rate which makes the development of an effective global vaccine very likely.

23 March 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AEAbdelmajid Eloualid
Abdelmajid Eloualid
OAOmar Abidi
Omar Abidi
MCMajida Charif
Majida Charif
BHBrahim El Houate
Brahim El Houate
HBHOUDA BENRAHMA
HOUDA BENRAHMA
HRHassan Rouba
Hassan Rouba
The methylenetetrahydrofolate reductase (MTHFR) gene is one of the main regulatory enzymes involved in folate metabolism, DNA synthesis and remethylation reactions. The influence of MTHFR variants on male infertility is not completely understood. The objective of this study was to analyze the distribution of the MTHFR C677T and A1298C variants using PCR-Restriction Fragment Length Polymorphism (RFLP) in a case group consisting of 344 men with unexplained reduced sperm counts compared to 617 ancestry-matched fertile or normozoospermic controls. The Chi square test was used to analyze the genotype distributions of MTHFR polymorphisms. Our data indicated a lack of association of the C677T variant with infertility. However, the homozygous (C/C) A1298C polymorphism of the MTHFR gene was present at a statistically high significance in severe oligozoospermia group compared with controls (OR = 3.372, 95% confidence interval CI = 1.27–8.238; p = 0.01431). The genotype distribution of the A1298C variants showed significant deviation from the expected Hardy-Weinberg equilibrium, suggesting that purifying selection may be acting on the 1298CC genotype. Further studies are necessary to determine the influence of the environment, especially the consumption of diet folate on sperm counts of men with different MTHFR variants.

5 June 2014 in Biochemical Genetics
Verified
Journal Article
Closed access
PDF file
HBHOUDA BENRAHMA
HOUDA BENRAHMA
HCHicham Charoute
Hicham Charoute
KLKhaled Lasram
Khaled Lasram
RBRedouane Boulouiz
Redouane Boulouiz
RARym Kefi-Ben Atig
Rym Kefi-Ben Atig
ABAbdelhamid Barakat
Abdelhamid Barakat

3 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
MLMeriem laamarti
Meriem laamarti
TATarek Alouane
Tarek Alouane
SKSouad Kartti
Souad Kartti
MCM.W. Chemao-Elfihri
M.W. Chemao-Elfihri
MHMohammed Hakmi
Mohammed Hakmi
AIAzeddine IBRAHIMI
Azeddine IBRAHIMI
In late December 2019, an emerging viral infection COVID-19 was identified in Wuhan, China, and became a global pandemic. Characterization of the genetic variants of SARS-CoV-2 is crucial in following and evaluating it spread across countries. In this study, we collected and analyzed 3,067 SARS-CoV-2 genomes isolated from 55 countries during the first three months after the onset of this virus. Using comparative genomics analysis, we traced the profiles of the whole-genome mutations and compared the frequency of each mutation in the studied population. The accumulation of mutations during the epidemic period with their geographic locations was also monitored. The results showed 782 variant sites, of which 512 (65.47%) had a non-synonymous effect. Frequencies of mutated alleles revealed the presence of 38 recurrent non-synonymous mutations, including ten hotspot mutations with a prevalence higher than 0.10 in this population and distributed in six SARS-CoV-2 genes. The distribution of these recurrent mutations on the world map revealed certain genotypes specific to the geographic location. We also found co-occurring mutations resulting in the presence of several haplotypes. Moreover, evolution over time has shown a mechanism of mutation co-accumulation which might affect the severity and spread of the SARS-CoV-2. On the other hand, analysis of the selective pressure revealed the presence of negatively selected residues that could be taken into considerations as therapeutic targets We have also created an inclusive unified database ( http://genoma.ma/covid-19/ ) that lists all of the genetic variants of the SARS-CoV-2 genomes found in this study with phylogeographic analysis around the world.


1 May 2012 in Genetic Testing and Molecular Biomarkers
Verified
Journal Article
Closed access
HBHOUDA BENRAHMA
HOUDA BENRAHMA
OAOmar Abidi
Omar Abidi
LMLeila Melouk
Leila Melouk
MAMaria Ajjemami
Maria Ajjemami
HRHassan Rouba
Hassan Rouba
ABAbdelhamid Barakat
Abdelhamid Barakat
Aims: Type 2 diabetes mellitus (T2DM) is a major public health problem around the world. The C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase (MTHFR) gene have been reported to be associated with T2DM and its complications. This study aimed to investigate this association in the Moroccan population. Methods: A case-control study was performed among 282 Moroccan diabetic patients and 232 healthy controls. The MTHFR C677T and A1298C polymorphisms were genotyped by polymerase chain reaction, followed by enzymatic digestion with HinfI and MboII enzymes, respectively. Results: There was a significant association between C677T polymorphism and T2DM in both additive and dominant models. In addition, the 677T allele frequency differed significantly between the diabetic and control groups (26.06% vs. 33.20%, respectively). However, no significant association was found between A1298C polymorphism and T2DM. The frequencies of combined genotypes 677CC/1298AA and 677CT/1298AC differed significantly between the diabetic and control groups (32.62% vs. 20.61% and 9.57% vs. 17.55%, respectively). Conclusions: These results show an evident association between the MTHFR C677T polymorphism and T2DM in Moroccan patients but no significant association with the MTHFR A1298C polymorphism.